Poseida Therapeutics (PSTX)
(Delayed Data from NSDQ)
$2.92 USD
+0.27 (10.19%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $2.92 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.43 | 0.00% |
Earnings Summary
For their last quarter, Poseida Therapeutics (PSTX) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive earnings surprise of 41.86%. Look out for PSTX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.43 per share, reflecting a year-over-year decrease of 34.38%.
Earnings History
Price & Consensus
Zacks News for PSTX
Adaptimmune (ADAP) Down on End of Collaboration With Roche
PSTX: What are Zacks experts saying now?
Zacks Private Portfolio Services